Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

- This updated ESMO Clinical Practice Guideline provides key recommendations on the management of acute myeloid leukaemia (AML) including acute promyelocytic leukaemia (APL).

- Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe.

- A summary of recommendations is provided, including levels of evidence and grades of recommendation where applicable.

- Recommendations take the approval status of AML drugs in Europe into account until the year 2019.

- Detailed guidance on diagnosis, classification, response assessment, treatment and follow up is provided for adults with AML and APL.


Read full Guideline